(Q69586165)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

title

Phase I clinical trial and pharmacokinetic evaluation of 4'-0-tetrahydropyranyladriamycin (THP-adriamycin) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

main subject

phase I clinical trial

1 reference

1 reference

M N Raber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

R A Newman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

K Lu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

S Legha

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

C Gorski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

R S Benjamin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

I H Krakoff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

3 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

page(s)

311-315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2706737%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00292410

3 October 2019

exact match

0 references

cites work

Tetrahydropyranyl derivatives of daunomycin and adriamycin

1 reference

12 December 2020

Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin

1 reference

12 December 2020

Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin

1 reference

12 December 2020

Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.

1 reference

12 December 2020

A high performance liquid chromatographic method of analysis of 4'-O-tetrahydropyranyladriamycin and their metabolites in biological samples

1 reference

12 December 2020

Doxorubicin Cardiomyopathy: Evaluation by Phonocardiography, Endomyocardial Biopsy, and Cardiac Catheterization

1 reference

12 December 2020

Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin

1 reference

12 December 2020

Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.

1 reference

12 December 2020

Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and light microscopy

1 reference

12 December 2020

Pharmacokinetics and disposition of (2''R)-4'-O-tetrahydropyranyladriamycin in dogs

1 reference

12 December 2020

Phase I clinical trial of a new anthracycline: 4'-o-tetrahydropyranyl adriamycin

1 reference

12 December 2020